key: cord-0789400-zigivjki
authors: Xu, Zhenxing; Su, Chang; Xiao, Yunyu; Wang, Fei
title: AI for COVID-19: Battling the pandemic with computational intelligence
date: 2021-10-21
journal: Intell Med
DOI: 10.1016/j.imed.2021.09.001
sha: f02e3f79a36cd77ecd2392fa944b661363d7198a
doc_id: 789400
cord_uid: zigivjki

The new coronavirus disease 2019 (COVID-19) has become a global pandemic leading to over 180 million confirmed cases and nearly 4 million deaths until June, 2021, according to the World Health Organization. Since the initial reported from December 2019 in Wuhan, China, COVID-19 has demonstrated a high transmission rate (with a R0 > 2), a diverse set of clinical characteristics (e.g., high rate of hospital and intensive care unit admission rates, multi-organ dysfunction for critically ill patients due to hyperinflammation, thrombosis, etc.), and tremendous burden on health care systems around the world. To understand the serious and complex disease and develop effective control, treatment, and prevention strategies, researchers from different disciplines have been making significant efforts from different aspects including epidemiology and public health, biology and genomic medicine, as well as clinical care and patient management. In recent years, artificial intelligence (AI) has been introduced into the healthcare field to aid clinical decision-making for disease diagnosis and treatment such as detecting cancer based on medical images and has achieved superior performance in multiple data-rich application scenarios. In the COVID-19 pandemic, AI techniques have also been used as a powerful tool to overcome the complex disease. In this context, the goal of this study is to review existing studies on applications of AI techniques in combating the COVID-19 pandemic. Specifically, these efforts can be grouped into the fields of epidemiology, therapeutics, clinical research, social and behavioral studies and are summarized. Potential challenges, directions, and open questions are discussed accordingly, which may provide new insights into addressing COVID-19 pandemic and would be helpful for researchers to explore more related topics in the post-pandemic era.

The unprecedented outbreak of new coronavirus disease 2019 (COVID-19) has put people around the world at risk. The COVID-19 pandemic originated from Wuhan, China, in December 2019 and spread throughout other countries of the world quickly because of a high transmission rate (with R0 value bigger than 2) [1] . The scarcity of resources and the worry of overburdened healthcare systems has impelled majority governments to restrict traveling or lockdown cities [2] . The COVID-19 pandemic has caused over 180 million confirmed cases and nearly 4 million deaths until June 2021, according to the World Health Organization [3] . Scientists have identified genome sequence of the virus and asserted it to be a member of the β-CoV genera of the coronavirus family [4] , which can attack human respiratory system, cause fever, cough, and other flu-like symptoms, and further affect multiple tissues and organ systems [5] . In addition, patients with COVID-19 may rapidly develop serious dysfunctions and even critical illness, leading to a suddenly boosted requirement of hospital beds, mechanical ventilation devices, and critical patient care resources [6] . Therefore, there is an urgent need for new technologies to help clinicians and health care providers to address this worldwide health crisis.

Artificial intelligence (AI), advanced by the rapid development of computer hardware and software and mathematics, is a wide range of techniques that allow computers thinking and working like human brain to support decision making. AI techniques, especially the machine learning (ML) and deep learning (DL), have demonstrated superior performance in many real-world data applications ranging from computer vision to natural language processing. In recent years, AI techniques have also been introduced into the healthcare field and lead to a new route to effectively derive knowledge in terms of disease conditions from complex health data to improve human health care, such as clinical decision-making [7] [8] . In COVID-19, the increasing availability of diverse types of data makes it promising to apply AI techniques to assist us to overcome the pandemic [9] . In this context, significant efforts that used AI to address COVID-19 have been drawn from different perspectives, including epidemiology and public health, biology and genomic medicine, as well as clinical care and patient management, etc. In this study, we discussed the applications of AI that mainly focused on ML and DL techniques in There are several previous studies in terms of using AI for fighting COVID-19 [10] [11] [12] [13] [14] . They generally have a specific focus on AI's applications in epidemiology and therapeutics in COVID- 19 . Muhammad et al. [11] surveyed 35 studies on the use of AI in COIVD-19 diagnosis, epidemic forecasting, and patient management. Hussain et al. [12] focuses on big data, Internet of Things (IoT), AI, cloud computing techniques in fighting against the COVID-19 pandemic. In addition, Pham et al. [13] , Chen et al. [14] and Nguyen et al. [10] also discussed the use of AI in vaccine and drug development. Compared to the previous studies, we considered a broader spectrum of application areas of AI in fighting against the pandemic, including epidemiology, therapeutics, clinical research, social and behavioral studies. In each field, we review existing studies and detail how the AI techniques advanced COVID-19 study, but also discuss unsolved issues and challenges as well as potential opportunities of AI in this field which may provide insights for researchers to bridge the gap between the application of AI and health care in the pandemic. The overall framework of this review is shown in Figure 1 .

References for this Review were found through searches of PubMed, Scopus, Google Scholar, and Web of Science for papers. Keywords include "COVID-19" "SARS-CoV-2", "nonpharmaceutical public health interventions", "epidemic control", "drug repositioning", "drug repurposing", "network medicine", "machine learning", "artificial intelligence", "convolutional neural networks", "deep learning", "subphenotyping", "misinformation", "social media", "health impacts", "public health", and "mental health". The titles and abstracts were furtherly checked for inclusion. Some relevant papers were also collected from the review of citations referenced. Most of the reviewed articles were published after June 2020. To clearly summarize these articles, we grouped them into four categories according to the types of applications, including (1) epidemiology, (2) therapeutics, (3) clinical research, (4) social and behavioral studies.

The data-driven-based statistical models mainly include regression-based parametric or non-parametric models such as Auto-Regressive Integrated Moving Average (ARIMA), Support Vector Regression (SVR), Random Forest (RF), deep learning (DL) model like Recurrent Neural Network (RNN), and so on. For example, Parbat and Chakraborty [15] used the SVR model to predict the COVID-19 trend to the total number of deaths, recovered cases, cumulative number of confirmed cases, and number of daily cases using the Johns Hopkins epidemiological data [16] . The proposed model was efficient and presented higher accuracy than linear or polynomial regression methods. While building a predictive model for COVID-19 trend forecasting, these pure data-driven-based statistical models typically only considered building relationships between a dependent variable such as the number of deaths and independent variables such as the number of days, but didn't explicitly consider the epidemiological characteristics of the infectious disease.

The aim of compartment models is to divide entire populations into multiple different compartments (i.e., states) such as susceptible, exposed, infectious and recovered, and then apply ordinary differential equations (ODEs) to model the transitions among these compartments. Two popular compartment models including Susceptible-Infected-Resistant (SIR) [17] and Susceptible-Exposed-Infected-Removed (SEIR) [18] are used to model the spread of infectious disease in terms of multiple previous epidemic outbreaks such as SARS [19] and the ongoing COVID-19 [20] [21] . Compared to data-driven-based statistical models, the compartment models were built on the well-established mathematical/physical laws, which consider the epidemiological characteristics of infectious disease and there is an assumption for the compartment models that the counts observed from these compartments have the potential to reflect reproduction numbers. Compartment models are still the mainstream approach in epidemiological research of infectious disease [22] . However, determination of parameters of the traditional compartment models are difficult and usually rely on predefined hypotheses. The use of AI techniques has shown their strength in estimating the optimal parameters of the compartment models, and hence led to a new way to improve the compartment models in COVID-19 trend prediction [23] [24] .

Recently, several researchers have utilized fine-grained methods to model a population through agent simulation for COVID-19 trend prediction [25] [26] . An individual based agent model is to simulate a real environment in an abstract representation to estimate the spread of epidemic diseases, which has three main elements including the agent (e.g., person), the factors of each agent (e.g., age), and the links between agents. Adel Alzu'bi et al. [26] used an individual based agent model to simulate the spread of COVID-19 in an urban area by considering multiple agent factors including age, gender, smoking status and isolation tendency. They found that the non-pharmaceutical public health interventions, such as staying home, hospital isolation policies, and preventing travel between cities, made contributions to the reduction of the prevalence and the deaths in COVID-19 pandemic.

In addition, some hybrid models such as the combination of mechanistic disease transmission model and a curve-fitting model [27] and the combination of RNN model and susceptible-infected (ISI) model [24] , have been used in the COVID-19 trend prediction. These hybrid models mainly considered the combination in terms of epidemiology model and ML techniques, which not only capture the epidemiological characteristics of infectious disease but also enhance the ability of building the relationships between input data and output data by pure data-driven method. The epidemiology model in a hybrid model is usually used to obtain information related to COVID-19 trends such as infection rates, which are utilized as input features for the AI prediction model. The hybrid models have also showed great promise to accelerate the COVID-19 trend prediction.

From the above summary, we can observe that multiple AI-based epidemiology models have been used to predict the spread of COVID-19 and obtain some promising initial results. However, there remain several challenges and opportunities for the improvement of predictive performance. Specifically, (1) The spread of infectious disease like COVID-19 is usually complex and influenced by multiple factors such as population density, demographic composition, weather conditions, non-pharmaceutical public health interventions, medical resource disparities, city traffic flows and so on [28] [29] [30] [31] [32] . Researchers need to consider how to combine these factors and set different weights for them. Investigating the impact of individual factors on the spread of COVID-19 trend is also an interesting topic.

(2) The epidemiology-based compartment models are sensitive to the initial values of model parameters such as infectious population, hospitalized population, and dead population. The determination of initial values of these parameters is usually based on the public reported data (including confirmed cases and recovered cases). However, the reported cases may not be very correct and usually much less than their real numbers because of multiple kinds of reasons such as the test capability [33] . Although integrating data-driven machine learning methods can relieve the dependence of initial values and improve the predictive performance, the regular (weekly or daily) updating for AI models to reflect changing dynamics is challenging because of more and more confirmed cases that need more train time. (3) The mutations of COVID-19 have been found [34] , which were more transmissible.

The mutated viruses may have higher fatalities, which influence the patterns of the spread of infectious disease. Incorporating mutation when building predictive models for the COVID-19 trend is important [35] but rarely discussed. (4) Building hybrid models by combining multiple predictive models is a good method for improving accuracy of predictive models. However, most previous hybrid COVID-19 trend predictive models mainly use the output of one model as the input feature of another model. Building a voting mechanism from many different predictive models would be beneficial for the predictive performance.

There are two common strategies for development of drugs to treat diseases including traditional drug development (de novo drug discovery) and drug repurposing [36] . The traditional drug development method usually starts from building novel chemical compounds based on molecular units and needs multiple steps including preclinical research, safety review, clinical study, FDA review, and FDA postmarket safety monitoring, which usually take more than 10 years and over 1$ billion to bring a drug to market [37] . Compared to traditional drug development methods, drug repurposing technique is usually used to identify drugs for emerging and challenging diseases treatment based on approved or investigating existing drugs, which has the potential to significantly reduce development timelines and a large number of costs [38] . During the current COVID-19 pandemic, the drug repurposing is a very promising approach for discovering effective drugs from existing drugs to treat patients with COVID-19 [39] . There are three common strategies for finding drugs in terms of new use by drug repurposing method, including through serendipity, using experimental screening platforms, and computational methods [40] . The serendipity drug repurposing is based on specific pharmacological insights in the lab and clinic. The experimental method based drug repurposing is usually to bind assays to identify relevant target interactions using some techniques such as affinity chromatography and mass spectrometry, which is costly and time-consuming [41] . Computational method based drug repurposing is mainly data-driven, which involves systematic analysis on multiple types of large-scale data such as gene expression, chemical structure, genotype or proteomic data or EHRs to acquire meaningful interpretations for repurposing hypotheses [40] . This method provides a great chance for identifying drugs quickly [42] .

The methods of computational drug discovery can be roughly divided into two categories: Structure-based drug discovery and ML based drug discovery. Structure-based drug discovery is one of most popular methods in discovering antiviral drugs, which uses the technique of computational high-throughput ensemble docking and the binding affinities are obtained by physics-based equations [43] . The ML based drug discovery is to use ML techniques to obtain the representations of drugs or diseases, and then measure the similarities of these entities or build predictive models to obtain the relationships between drug and disease [36] . During COVID-19 pandemic, the process of simulations and docking in structure-based drug discovery need to be refined and repeated because there are multiple new experimental three-dimensional structures of the S protein and other viral targets [44] . Researchers have started to use ML techniques instead of structure-based drug discovery to predict drug binding and find candidate drugs due to the superiority of ML [45] . In ML based drug repurposing, the representation of structure of drug and disease is key for training ML models. Drug repurposing using regular and irregular data structure representations are discussed as follows. A general framework of ML based drug repurposing is demonstrated in Figure 2 .

Regular data structures including vector, sequence, and matrix have been used for drug repurposing with different DL architectures [40] . In particular, for vector representation of drugs or diseases, a fully connected feedforward neural network (FNN) architecture is usually used to build a predictor or classifier [46] . In FNN, the input variables and output targets are connected by multiple layers with neurons. Each neuron from the preceding layer is connected to all neurons from the subsequent layer, and those connections are assigned different weights, which are trained and optimized through prediction loss and backpropagation. There are several FNN based drug repurposing studies [47] [48] [49] The matrix representation of drugs mainly refers to chemical images, which contain more molecular structure information. In this context, the advanced CNN [50] , a preferred DL model specifically designed to obtain insights from those images, could be a promising approach to address the tasks. CNN is able to build relationships between the pixels in images and final predictive targets by multiple layers of nonlinear transformations [51] . A CNN typically consists of three layers: a convolution layer, a pooling layer, and a fully connected layer. CNN has been applied to explore drug function based on chemical images [52] . For example, Wallach et al. [53] used a CNN to build a predictive architecture, AtomNet, to predict molecular binding affinity to proteins, which obtained an AUC larger than 0.9 on 57.8% of the targets in the DUDE benchmark. Ragoza et al. [54] used CNN to build a protein-ligand scoring system to classify compound poses as binders or nonbinders. A grid representation of protein−ligand structures was used as input of CNN model, which showed better discrimination than AutoDock Vina scoring [55] in terms of pose prediction and virtual screening.

In addition, some studies focused on modeling molecular sequence of drugs to identify new therapeutic implications. In this context, the recurrent neural networks (RNNs) [56] , a kind of DL model for sequence data modeling, are usually involved. In a RNN, a recurrent neuron is used to address each element of a sequence at each timestamp, and integrates the historical information of the current element, which is obtained from the output of previous timestamp. There are several studies that used RNN to generate simplified molecular input line-entry system (SMILES) with desirable properties such as quantitative estimate of drug-likeness (QED) [57] . By fine tuning a pre-trained RNN, Olivecrona et al. [58] solved the issue in terms of a combination of handwritten rules for undesirable structure penalties. In addition, RNN architectures have been applied to generate focused molecule libraries for drug discovery by building sequence profiles for molecules based on SMILES codes [59] . Gao et al. [60] designed a hybrid of RNN and graph-based CNN model to identify drug-target interactions based on amino acids sequences and chemical structures.

Irregular data structure based drug repurposing mainly involves network medicine [61] [62] and graph representation learning [63] . Typically, a biomedical network or biomedical knowledge graph was first built. Then graph-based AI models, e.g., network embedding or deep graph neural networks, were used to learn low-dimensional representations for nodes and edges while preserving the graph structure. Finally, novel drug implication (e.g., potential drug-disease associations or drug-target interactions) discovery can be done by link prediction based on those representations [39, 64] 

Although computational drug repurposing has shown large potential for identifying effective drug candidates for treating COVID-19 infections, there remain challenges and opportunities for improving the efficiency of discovering drugs. In particular,

(1) Current dataset for computational drug discovery is very small. Although a gigantic collection GDB-17 has 166 billion compounds, it is only a tiny fragment of the chemical universe [67] . The ML methods may show poor performance when the model encounters compounds that the molecules have not been seen in train sets. The structure-based drug discovery needs accurate crystal structures to obtain better matching results in terms of proteins with drugs [45] . Building a larger and better dataset that contains more kinds of accurate crystal structures is beneficial for drug discovery, which may need more time, money and expertise. (2) The Biomedical knowledge graph (BKG)-based approaches for drug development typically rely on quality of the BKG used. Different resources were used to build the BKGs in different projects, which may hence produce bias during discovering the promising repurposing drug candidates of COVID-19. There are efforts such as Heteionet [68] and our BKG [69] aiming at incorporating and harmonizing data from diverse medical domains and resources to build comprehensive BKGs, however there is no golden standard to evaluate quality of them. This may limit reliability of the identified therapeutic implications. (3) Computational data scientists need to work closely with chemists or doctors, which is very key. For example, extracting a broad range of properties of molecules based on domain knowledge from chemical experts is helpful for obtaining complete representation of molecules and then feeding them to ML models has the potential to improve model performance. When building a knowledge graph, some clinicians and medical school students may need manually reviewed clinical reports to aid model training, which may involve bias. More domain experts should work on them and the model developer should iteratively combine feedback from doctors who utilized the developed tool.

The studies of AI in COVID-19 clinical research can be roughly divided into two types ( Table 3) : the diagnostic and prognostic prediction of COVID-19 and the subphenotyping of COVID-19. For the former, researchers use ML techniques to build classifiers to identify or predict patients whether or not suffering from COVID-19 or different levels of severity of COVID-19. For the latter, researchers focus on using clustering methods to identify subgroups, and furtherly investigate the different characteristics such as hospitalization, intensive services, and death of these sub-groups.

Early and rapid identification of COVID-19 is urgently needed [70] [71] , which not only is important for immediate management and treatment of individual patient care but also provides guilds for public health in terms of patient isolation and COVID-19 containment [72] . A COVID-19 virus-specific reverse transcriptase polymerase chain reaction (RT-PCR) test is widely utilized to detect the COVID-19 disease [73] . However, this test usually takes up to two days to obtain final results, and serial tests may be considered to exclude the possibility of false negative results, which may underestimate the situation of COVID-19 pandemic and hinder government control in terms of disease transmission and healthcare workforce [72] . Recently, researchers have used data-driven methods to build classifiers with historical medical information for diagnosis or prediction. In particular, researchers have used image or non-image medical information to build classifiers. For image based studies, they trained classifiers with ML methods using extracted features from medical images, such as human lung CT scan images, chest X-ray, and ultrasound images, or use DL models to build classifiers on raw medical images. For non-image based studies, they extracted EHR information such as routine lab tests and integrated ML models to train a classifier or built a score system using selected predictors. A general framework of using AI techniques for COVID-19 patients' prediction is shown in Figure 3 .

Three common types of images including CT image, chest X-ray, and ultrasound images are used to build classifiers to perform COVID-19 diagnosis. With a more accurate tool in CT scans, CT images usually contain more information that are useful for COVID-19 diagnosis [5] . Most previous CT image based studies mainly use CNN for COVID-19 diagnosis [5, [74] [75] [76] . For example, Xu et al. [74] used a CNN architecture to extract lung CT image spatial features from 618 CT images for diagnosing COVID-19, influenza-A viral pneumonia and healthy cases. Although CT image is a valuable component for COVID-19 diagnosis, CT imaging usually takes more time than X-ray imaging and causes more harm for patients because of more exposure to radiation. In addition, compared to CT imaging machines, the equipment for X-ray is low cost and easy to operate, which attracted researchers' attention to COVID-19 diagnosis [77] [78] [79] [80] . For example, Wang et al. [78] built a hybrid model with CNN and SVM for diagnosing COVID-19 on two datasets including 1,102 and 625 chest Xray images, which obtained the 99.33% and 95.02% of accuracy, respectively. More recently, clinicians have found that lung ultrasound images can show higher sensitivity than chest X-ray in diagnosing pneumonia in some cases [81] [82] . Due to the characteristics of a more widely available, lower cost, more safe, and real-time ultrasound imaging technique, using lung ultrasound images for diagnosis of COVID-19 is obtaining attention [83] [84] . Roy et al. [84] used lung ultrasound images to predict disease severity using a deep network by integrating spatial transformer networks and CNN, which showed accurate prediction and localization of COVID-19 imaging biomarkers. These previous studies with images mainly use DL techniques to extract spatial information and build classifiers, which need more samples for training classifiers to obtain best performance. Data augment techniques have been considered to deal with the lack of medical image for COVID-19 diagnosis [80, 85] . Loey et al. [85] used a GAN with deep transfer learning based data augmentation techniques to strengthen original 306 chest X-ray images to 8,100 images for COVID-19 detection.

Non-image based classification of COVID-19 focuses on using EHR information to diagnose COVID-19, which consists of two types of studies: score system based and ML based COVID-19 diagnosis. For the former, researchers seek to identify important predictors, assign to their scores, sum these scores and discriminate the severity of disease [86] [87] 

Clinical subphenotyping is to divide patients who share a phenotype into several clusters [92] . Patients in a same cluster have similar characteristics such as demographics, clinical characteristics, treatments, comorbidities, and outcomes, which differentiate the cluster from other clusters [93] . The identification of subphenotypes is helpful for understanding the pathophysiology of critical care syndromes and can lead to personalized treatment and management [94] . Recently, data-driven subphenotyping has been explored for multiple diseases such as sepsis [95] , asthma and allergies [96] . A general framework of using AI techniques for subphenotyping patients is shown in Figure 4 .

The studies of COVID-19 subphenotyping can be roughly divided into two categories including static subphenotyping and dynamic subphenotyping. For the former, the researchers first extract patient clinical variables presenting at admission to the emergency department, hospitalization, or ICU, and then use clustering methods such as hierarchical clustering method, consensus cluster analysis method, and self-organizing map (SOM) to identify clusters, and finally investigate the characteristics such as comorbidities and outcomes of these clusters [97] [98] [99] [100] [101] subphenotypes showed different characteristics. These static variable based subphenotyping studies mainly identify the short term subphenotypes, which may ignore the information in terms of progress of disease and treatment. Although previous studies have discovered several subphenotypes, due to the variable presentation to health care after developing symptoms and the evolution of organ failure in critical care [102] , static assessments of COVID-19 may be incomplete.

For the dynamic subphenotyping, the researchers consider the trajectory of variables during a long term period such as 3 days and use trajectory based clustering methods such as dynamic time warping (DTW) [103] and group-based trajectory modeling (GBTM) to identify clusters [104] . For example, V. Bhavani et al. [104] used the dynamic trajectories of COVID-19 patient temperature to identify subphenotypes. The differential pattern of temperature change may provide cues to a varied underlying inflammatory response to infection. However, this study only used the trajectory of a single variable, which may ignore the influence from other organ dysfunction. To consider trajectory from multiple organ dysfunction can refine the understanding of the natural history of COVID-19 in response to standard of care treatment and define patterns of disease that may benefit from novel therapeutic strategies [105] . Su et al. [103] used the trajectory of sequential organ failure assessment that described dysfunctions in six organs including respiration, coagulation, liver, cardiovascular, central nervous system, renal, to identify subphenotypes among the critically ill patients with COVID-19. They discovered distinct worsening and recovering subphenotypes within different baseline severity strata. Compared to baseline severity of illness, demographics and comorbidities, dynamic inflammatory markers and ventilator variables showed much difference between worsening and recovering subphenotypes. These dynamic variable based subphenotyping studies consider the longitudinal variable trajectories and have demonstrated great promise to achieve unique insights into the multiorgan dysfunction.

Although clinical research including building predictive models and subphenotyping COVID-19 patients have been paid more attention and promising initial results have been obtained, there are some challenges or opportunities. Specifically,

(1) Most of the previous clinical research in COVID-19 mainly used structured information such as demographic, lab tests, vital signs, to build the representation of patients for ML modeling. Unstructured information such as clinical notes, the reports of CT scan images may contain more detailed information for COVID-19 diagnosis. For example, Obeid et al. [106] performed text information analysis based on patients' self-reported symptoms to predict COVID-19 infection risk by a word embedding-based CNN. The unstructured information can be used as complementary information for structured information [107] . Integrating structured and unstructured information has the potential to completely represent the patient and improve model performance. How to integrate these information still needs to be investigated by researchers.

(2) For COVID-19 subphenotyping studies, validating the discovered subphenotypes on external sites is very important. However, the distribution difference between derivation cohort and validation cohort such as the size of cohort or heterogeneity of risk factors may generate different subphenotypes. Designing a method to measure the discrepancy of distribution and integrating them into a ML model may make contributions for identifying subphenotypes. (3) Current static variables based subphenotyping studies mainly identify subphenotypes for patients at admission to the emergency department or ICU. These discovered subphenotypes may be too early for those patients, which may ignore the progress of COVID-19. Choosing proper time such as the first 6 hours after admission for subphenotyping patients may be able to avoid premature phenotyping [95] . (4) Although dynamic based COVID-19 subphenotyping considered the longitudinal trajectories and has the potential to obtain comprehensive understanding in terms of the natural history of COVID-19, it is still challenging to set a proper time interval for extracting features and build a representation for each patient based on trajectory.

The outbreak of COVID-19 produced an impact on people's daily behavior. Several specific topics including information search behavior change, the impact of misinformation, psychosocial impacts, mobility network, and contact tracing have been investigated. In particular, for information search behavior change, researchers want to know what kinds of key information would be searched popularly by citizens during COVID-19 pandemic. For example, Bento et al. [108] investigated information-seeking responses to the first COVID-19 case public announcement in a state. They found more people searched information in terms of "coronavirus", "coronavirus symptoms", and "hand sanitizer" after the first case announcement, which increased by about 36% (95% CI: 27% -44%) on the day immediately and fell back to the baseline level in less than a week or two. The information about community-level policies such as quarantine and personal health strategies such as grocery delivery were not paid more attention, which indicated the study period was relatively early in the epidemic and there were limited elaborate policies from public discourse.

Investigating the information search behavior change can help the government to take proper measures. However, there is a large amount of misinformation in terms of COVID-19, which may mislead people's decision [109] [110] [111] . Bursztyn et al. [112] discovered the relationship between misinformation and health outcomes based on the two most popular cable news shows including Hannity and Tucker Carlson Tonight in the United States. An epidemiological model was used to measure the magnitudes in terms of treatment effects, which highlighted the relevance of externalities. They found that misinformation on mass media had significant social consequences. In order to identify low credibility news, Zhou et al. [113] constructed a repository based on 2,029 articles from about 2,000 news publishers and 140,820 tweets, which included multiple types of information on coronavirus, such as textual, visual, temporal, and network information. Several ML method based predictive models were built for identifying fake news and obtained competitive performance.

Investigating social media furtherly can find the cues in terms of psychosocial impacts during COVID-19 [114] [115] [116] . Saha et al. [117] discovered the temporal and linguistic changes in symptomatic mental health and support expressions during the COVID-19 pandemic by comparing Twitter streaming posts collected in the year of 2020 and 2019. They found that there is a significant increase in terms of people's mental health symptoms and support expressions during the COVID-19 period. Linguistic analyses showed that people express more concerns in terms of the COVID-19 crisis. Zhang et al. [118] built a fusion classifier that integrated DL model, psychological text features, and demographic information to investigate the relationships between feature and depression signals. The proposed model demonstrated an accuracy of 78.9% and has been used to analyze the depression level of different groups of people on Twitter in terms of three US states (New York, California, and Florida). They found people in Florida had a substantially lower level of depression.

In addition, investigating the spread patterns of cases and tracking individuals' movement are useful for controlling the spread of COVID-19. Chang et al. [32] used a metapopulation susceptible-exposed-infectious-removed (SEIR) model based on fine-grained and dynamic mobility networks to investigate the spread of COVID-19 in 10 US metropolitan areas. The built SEIR model can fit real case trajectory and reveals that setting specific occupancy for different points of interests is more effective than uniformly restricting mobility. With the wide use of smartphones, developing apps can facilitate the tracking of individuals' movements. Ahmed et al. [119] introduced three different kinds of smartphone contact tracing apps based on different ways of using servers and storing data, including centralized, decentralized, and hybrid architecture contact tracing apps. These apps have been used to identify and trace all recent contacts of newly discovered infected individuals.

Although more and more researchers have paid attention to behavioral and social sciences during COVID-19 pandemic, there are some challenges or opportunities. Specifically,

(1) Bias of data source: most previous studies used social media data from multiple data sources such as different news publishers or Tweet posts. There may be bias for those news publishers. Identifying those biases and integrating them into the model may be helpful for detailed analysis. In addition, there are other types of data such as image and video, which can be integrated with text information to provide more insights for the analysis of COVID-19. (2) Data privacy for tracing apps: although current apps have used some techniques such as decentralized contact tracing to keep privacy, a fully decentralised architecture has not been proposed [119] . A technique of using a peer-to-peer network may facilitate privacy-preserving information sharing amongst the userdevices. (3) Behavioral changes in different groups such as old and young groups may be different during COVID-19 pandemic [120] . Interesting findings may can be found if researchers perform more fine-grained analysis. The government would take proper measures to provide assistance for those who may suffer from severe health problems such as depression or anxiety in different groups. (4) Most previous studies on behavioral changes mainly focused on patients with COVID-19. Currently, with more and more citizens who get vaccinated, investigating the changes of mental health problems after vaccination may be interesting.

In previous sections, we reviewed studies using AI to address the COVID-19 pandemic from epidemiology, therapeutics, clinical research, social and behavioral aspects, and discussed the potential challenges and opportunities for each kind of application. This section will discuss existing challenges, potential directions and open questions from a general perspective.

Model interpretation is very important in the medical domain because model outputs (e.g., diagnosis) without reasonable reasons make no sense to clinicians [121] . Different types of models may need different types of explainability. Previous models for COVID-19 analysis can be divided into two types: models built on ML and non-ML techniques. For models built on non-ML techniques such as using risk scores, it is not very difficult to explain final results by investigating each risk variable and other related clinical EHR information, which can be seen as intrinsic interpretability [122] . For example, Liang et al. [86] built a predictive risk score (COVID-GRAM) system, which used 10 important factors from the epidemiological, clinical, laboratory, and imaging variables, to estimate the risk of developing critical illness for patients with COVID-19 admitted to the hospital. When interpreting the COVID-GRAM, clinicians only check scores of specific variables among these 10 factors. In addition, clinicians may modify their assessment if they find some values of variables are obviously abnormal. Intrinsically interpretable models based on non-ML techniques can provide better interpretability for clinicians, however, building models based on risk factors is not easy because more professional knowledge is necessary for developers to choose important risk factors.

With a larger amount of EHR, more and more ML models have been used in clinical applications. For models based on ML techniques, the interpretability can be seen as post hoc interpretation [122] . There are two directions for obtaining interpretable ML modeling. One is to derive explainable tools that show the contribution of input features to the final output. Several explainable tools such as LIME [123] and Shapley Additive Explanation [124] have been developed to determine the feature contributions by assigning importance scores. Adding attention mechanisms to hidden layers in DL models can also contribute to model interpretability [125] . Another key aspect is to interpret complex models based on multiple relatively simple models. For example, outputting the results of each convolutional layer of CNN in identifying specific regions of an image may provide cues for explaining final output results [126] . In addition, considering different levels of explainability in different applications may be sensible [122] . For example, clinicians may be relatively comfortable utilizing black-box models for some specific clinical applications (e.g., image analysis) that clinicians can readily intervene in. On the other hand, applying the black-box model to address unexplored problems may cause less comfort for clinicians.

Though ML models have been widely used in COVID-19 related applications, increasing evidence has been found that existing ML models could be fooled by adversarial examples and hence hard to obtain desirable performance [127] [128] . Adversarial examples are models' inputs that are intentionally designed to make a mistake such as misclassification for identifying COVID-19 cases on medical IoT (Internet of Things) devices, which may poison the learning or the inference processes and furtherly compromise the security of ML models [129] . Recently, adversarial examples have been one of the most popular research topics in ML communities [130] . Although some studies in terms of adversarial examples have been done, two directions may be necessary for investigating the detection and defense mechanisms in terms of COVID-19 DL poisoning process. One is to employ blockchain techniques to address adversarial example attacks on COVID-19 applications. For example, Nassar et al. [131] utilized blockchain to save benign attributes and parameters of each DL model, and furtherly transfer them to explainable AI for high-level users to check whether a particular model is compromised or not. Another is to study transferable adversarial examples [132] , which have the potential to show better defense mechanisms against inference and model poisoning. Additionally, applying real-world attacks to test DL models and using industry standards such as IBM Adversarial Robustness Toolbox (ART) [133] to estimate and defend DL models against adversarial threats should be encouraged.

AI techniques have become more ubiquitous for users to make or assist decisions in multiple domains such as recruiting (screening job applicants), banking (credit ratings/loan approvals), and judiciary (recidivism risk assessments). However, bias concern has been paid more attention recently by researchers in terms of whether the learned scoring function in ML model can make fair decisions in those real-world applications [134] . The bias in ML can be seen as the phenomenon of observing results that the learned model is systematically prejudiced across different groups defined by sensitive variables such as race or gender [135] . The bias may give rise to discrimination for protected groups and lead policymakers to make unfair decisions in real-world applications [136] . Detecting the bias and reducing its likelihood in model design and execution would play more critical roles in creating a fair treatment for specific populations [137] .

The bias in ML that may cause discrimination can be roughly divided into three types [138] [139] , including disparate treatment, disparate impact and disparate mistreatment. In order to better understand the different types of bias, we take an example ( [139] . This bias was found by Propublica in the Northpointe algorithm [140] , which misclassified innocent Black defenders as reoffending at twice the rate as White people.

Keeping the same percentages of accurate labels for all sensitive groups is useful for rectifying the mistreatment. The objective of ML is to optimize a cost function by minimizing the difference between function outputs and real results. Adding the constraints to the objective function by considering the above-mentioned bias can avoid discrimination. A trade-off between fairness and accuracy should be considered when adding constraints.

Privacy concerns are very important in applications of ML for healthcare. The "differential privacy" technique has been used to ensure model and data privacy in a single dataset [141] [142] . For example, Chaudhuri et al. [143] proposed differential private approaches to preserve parameters obtained from logistic regression model or support vector machines. However, it remains challenging for most AI models to address two issues: (1) more parameters to be safeguarded in DL models; (2) keeping privacy when integrating data from multiple sites. In order to keep balance between privacy and model precision, federated learning (FL) [144] , a framework of constructing a central parameter server to train a global model based on the parameters from multiple local sites that store their own sensitive data, has attracted more attention and offer great promise when integrating fragmented healthcare data from multiple medical sites with privacy-protection. More recently, Swarm Learning (SL) [145] , a decentralized ML framework that integrates edge computing, blockchain-based peer-to-peer networking and dynamic central coordinator, has been paid more attention. Warnat-Herresthal et al. [145] used the SL framework to perform predictions in terms of COVID-19, tuberculosis, leukaemia and lung pathologies to illustrate the feasibility of SL. Under the SL framework, a shared global model is trained with a dynamic central coordinator that aggregates parameters from local sites keeping their sensitive data. Blockchain-based peer-to-peer networking is used to keep parameters privacy during transferring. Thus, data and parameters obtain double protection in SL, which can go beyond FL in real-world applications. Although the performance of FL and SL models is usually better than the model trained on single local sites, there exists large room for improvement compared to the central model trained by aggregating data from all local sites without any consideration of privacy. How to improve model performance is still an important problem. In addition, most applications using the FL and SW framework mainly focus on disease risk prediction that is relatively simple. Employing these models for more complex applications such as medical treatment and providing medication prescripts may be more worth exploring.

In this study, we reviewed existing studies on using AI techniques to deal with COVID-19 pandemic related problems from four aspects including epidemiology, therapeutics, clinical research, social and behavioral studies. All the results available in those previous literature demonstrated the applicability and great promise of AI in addressing COVID-19 pandemic. Also, some challenges, directions, and open questions are provided in this review, which may be helpful for researchers to explore more related topics. A multiple mixedeffects logistic regression

The mortality rates for patients with COVID-19 were different between the months of March and April and later months in 2020, which were not fully explained by changes in age, sex, Table 4 . An example of a binary classification problem based on ML in terms of whether a loan would be returned using n+1 attributes (Q is a sensitive variable such as the user's race). Labels " " and "1" represent "Returned" and "defaulted", respectively. 

The reproductive number of COVID-19 is higher compared to SARS coronavirus

A comprehensive review of the COVID-19 pandemic and the role of IoT, drones, AI, blockchain, and 5G in managing its impact

COVID-19) Dashboard

Features, Evaluation, and Treatment of Coronavirus (COVID-19)

Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography

Immune dysfunction following COVID-19, especially in severe patients

Deep learning in mental health outcome research: a scoping review

Deep learning for healthcare: review, opportunities and challenges

Considerations for development and use of AI in response to COVID-19

Blockchain and AI-based solutions to combat coronavirus (COVID-19)-like epidemics: A survey

A survey on the use of AI and ML for fighting the COVID-19 pandemic

AI techniques for COVID-19

Artificial intelligence (AI) and big data for coronavirus (COVID-19) pandemic: A survey on the state-of-the-arts

A survey on applications of artificial intelligence in fighting against covid-19

A python based support vector regression model for prediction of COVID19 cases in India

An interactive web-based dashboard to track COVID-19 in real time

A contribution to the mathematical theory of epidemics

The mathematics of infectious diseases

Annual International Conference of the IEEE Engineering in Medicine and Biology Society

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions

Population stratification enables modeling effects of reopening policies on mortality and hospitalization rates

Epidemic model guided machine learning for COVID-19 forecasts in the United States

Predicting COVID-19 in China Using Hybrid AI Model

Predicting COVID-19 in China Using Hybrid AI Model

Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling

2021) IHME???

Population density, a factor in the spread of COVID-19 in Algeria: statistic study

Air transportation, population density and temperature predict the spread of COVID-19 in Brazil

Impact of temperature and relative humidity on the transmission of COVID-19: a modelling study in China and the United States

Impact of intervention on the spread of COVID-19 in India: A model based study

Mobility network models of COVID-19 explain inequities and inform reopening

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Leveraging a multiple-strain model with mutations in analyzing the spread of COVID-19

Framework for identifying drug repurposing candidates from observational healthcare data

Insights into Computational Drug Repurposing for Neurodegenerative Disease

Drug repositioning: identifying and developing new uses for existing drugs

Artificial intelligence in COVID-19 drug repurposing

Drug repurposing: progress, challenges and recommendations

A comprehensive map of molecular drug targets

Network-based approach to prediction and populationbased validation of in silico drug repurposing

A Structure-Based Drug Discovery Paradigm

How to Discover Antiviral Drugs Quickly

The drug-maker's guide to the galaxy

A hybrid particle swarm optimization-back-propagation algorithm for feedforward neural network training

Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data

Deep neural nets as a method for quantitative structureactivity relationships

DeepTox: toxicity prediction using deep learning

Understanding of a convolutional neural network

Convolutional neural networks: an overview and application in radiology

Learning Drug Functions from Chemical Structures with Convolutional Neural Networks and Random Forests

AtomNet: a deep convolutional neural network for bioactivity prediction in structure-based drug discovery

Protein-Ligand Scoring with Convolutional Neural Networks

AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

Recurrent neural networks for prediction: learning algorithms, architectures and stability

Quantifying the chemical beauty of drugs

Molecular de-novo design through deep reinforcement learning

Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks

Interpretable Drug Target Prediction Using Deep Neural Representation

Network medicine: a network-based approach to human disease

Network medicine framework for identifying. drugrepurposing opportunities for COVID-19

Network embedding in biomedical data science

Line: Large-scale information network embedding

A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare Diseases

Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning

The drug-maker's guide to the galaxy

Systematic integration of biomedical knowledge prioritizes drugs for repurposing

The Cornell Biomedical Knowledge Hub. medRxiv

Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam

China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China

Artificial intelligence-enabled rapid diagnosis of patients with COVID-19

Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine Learning

A Deep Learning System to Screen Novel Coronavirus Disease

Application of deep learning technique to manage COVID-19 in routine clinical practice using CT images: Results of 10 convolutional neural networks

A fully automatic deep learning system for COVID-19 diagnostic and prognostic analysis

Automatic detection of coronavirus disease (COVID-19) using Xray images and deep convolutional neural networks

An efficient mixture of deep and machine learning models for COVID-19 diagnosis in chest X-ray images

Automated detection of COVID-19 cases using deep neural networks with X-ray images

A deep learning approach to detect Covid-19 coronavirus with X-Ray images

Diagnostic use of lung ultrasound compared to chest radiograph for suspected pneumonia in a resource-limited setting

Lung ultrasound findings compared to chest CT scan in patients with COVID-19 associated pneumonia: a pilot study

Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus (COVID-19) Pneumonia?

Deep Learning for Classification and Localization of COVID-19 Markers in Point-of-Care Lung Ultrasound

Within the lack of chest COVID-19 X-ray dataset: a novel detection model based on GAN and deep transfer learning

Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19

Seek COVER: Development and validation of a personalized risk calculator for COVID-19 outcomes in an international network

An interpretable machine learning framework for accurate severe vs non-severe covid-19 clinical type classification

Hemogram data as a tool for decision-making in COVID-19 management: applications to resource scarcity scenarios

Machine learning prediction for mortality of patients diagnosed with COVID-19: a nationwide Korean cohort study

Early triage of critically ill COVID-19 patients using deep learning

Subphenotypes in critical care: translation into clinical practice

Using Latent Class Analysis to Identify Hidden Clinical Phenotypes

Identifying Novel Sepsis Subphenotypes Using Temperature Trajectories

Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis

Trajectories of asthma and allergies from 7 years to 53 years and associations with lung function and extrapulmonary comorbidity profiles: a prospective cohort study

Differences in clinical deterioration among three subphenotypes of COVID-19 patients at the time of first positive test: results from a clustering analysis

Identifying Clinical Phenotypes in Moderate to Severe Acute Respiratory Distress Syndrome Related to COVID-19: The COVADIS Study

Association of clinical sub-phenotypes and clinical deterioration in COVID-19: further cluster analyses

Clinical subphenotypes in COVID-19: derivation, validation, prediction, temporal patterns, and interaction with social determinants of health

Using machine learning of clinical data to diagnose COVID-19: a systematic review and meta-analysis

Serial evaluation of the SOFA score to predict outcome in critically ill patients

Identifying organ dysfunction trajectory-based subphenotypes in critically ill patients with COVID-19

Novel Temperature Trajectory Subphenotypes in COVID-19

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine

An artificial intelligence approach to COVID-19 infection risk assessment in virtual visits: A case report

Health informatics and EHR to support clinical research in the COVID-19 pandemic: an overview

Evidence from internet search data shows informationseeking responses to news of local COVID-19 cases

Impact of Rumors and Misinformation on COVID-19 in Social Media

Misinformation of COVID-19 on the internet: infodemiology study

Both Rates of Fake News and Fact-based News on Twitter Negatively Correlate with the State-level COVID-19 Vaccine Uptake

Misinformation during a pandemic

A multimodal repository for covid-19 news credibility research. International Conference on Information and Knowledge Management

Mental Health and the Covid-19 Pandemic

The COVID-19 pandemic and mental health impacts

Mental health in the COVID-19 pandemic

Psychosocial Effects of the COVID-19 Pandemic: Large-scale Quasi-Experimental Study on Social Media

Monitoring Depression Trends on Twitter During the COVID-19 Pandemic: Observational Study

A survey of COVID-19 contact tracing apps

COVID-19 Worries and Behavior Changes in Older and Younger Men and Women

Opportunities and challenges of deep learning methods for electrocardiogram data: A systematic review

Should health care demand interpretable artificial intelligence or accept "black box" medicine?

Explaining the predictions of any classifier

A unified approach to interpreting model predictions

Multilevel knowledge-guided attention for modeling electrocardiography signals

Visual interpretability for deep learning: a survey

Explaining and harnessing adversarial examples

Adversarial examples-security threats to COVID-19 deep learning systems in medical IoT devices

Adversarial attacks against medical deep learning systems

Blockchain for explainable and trustworthy artificial intelligence

The space of transferable adversarial examples

False positives, false negatives, and false analyses: A rejoinder to machine bias: There's software used across the country to predict future criminals. and it's biased against blacks

Dissecting racial bias in an algorithm used to manage the health of populations

Bias and Discrimination in AI: a cross-disciplinary perspective

Algorithms, correcting biases

Digital discriminationAlgorithmic Regulation

Fairness beyond disparate treatment & disparate impact: Learning classification without disparate mistreatment

Biases in AI systems

Joint UNECE/Eurostat work session on statistical data confidentiality

Non-interactive differential privacy: a survey

Differentially Private Empirical Risk Minimization

Federated Learning for Healthcare Informatics

Swarm Learning for decentralized and confidential clinical machine learning

Estimation of COVID-19 prevalence in Italy

Application of the ARIMA model on the COVID-2019 epidemic dataset

Deepcovid: An operational deep learning-driven framework for explainable real-time covid-19 forecasting

Kalman filter based short term prediction model for COVID-19 spread

Differential impact of non-pharmaceutical public health interventions on COVID-19 epidemics in the United States

The timing and effectiveness of implementing mild interventions of COVID-19 in large industrial regions via a synthetic control method

Predictive performance of international COVID-19 mortality forecasting models

Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months

Publisher Correction: The effect of large-scale anticontagion policies on the COVID-19 pandemic

ALeRT-COVID: Attentive Lockdown-awaRe Transfer Learning for Predicting COVID-19 Pandemics in Different Countries

High temperature and high humidity reduce the transmission of COVID-19

Global Access to Handwashing: Implications for COVID-19 Control in Low-Income Countries

IHME COVID-19 Forecasting Team. Modeling COVID-19 scenarios for the United States

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

COVID-19 literature knowledge graph construction and drug repurposing report generation

Drug repurposing for COVID-19 via knowledge graph completion

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model

Data-Driven Drug Repurposing for COVID-19

Evaluation of albumin kinetics in mechanically ventilated patients with COVID-19 compared to those with sepsis-induced ARDS. medRxiv

Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study

Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic

Machine learning analysis highlights the down-trending of the proportion of COVID-19 patients with a distinct laboratory result profile. medRxiv

Subphenotyping of COVID-19 patients at preadmission towards anticipated severity stratification: an analysis of 778 692 Mexican patients through an age-gender unbiased meta-clustering technique. medRxiv

The authors declare no conflicts of interest.